Forbes reports that a recent Merritt Hawkins survey shows that patients are waiting an average of 26 days for a scheduled appointment with a doctor. This is based on a 15 U.S. city survey of more than 1,000 physician offices - including family medicine, dermatology, obstetrics/gynecology, orthopedic surgery and cardiology practices. The average wait time is up 8% from 24.1 days in 2017 (It was 21 days in 2004).

Deucravacitinib (Sotyktu), a first-in-class, oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, is the only approved TYK2 inhibitor worldwide and the first innovation in oral treatment for moderate-to-severe plaque psoriasis in nearly 10 years.